/wp-content/uploads/4dmt_logo.svg00Maria Gonzalez/wp-content/uploads/4dmt_logo.svgMaria Gonzalez2026-07-20 14:15:232026-07-20 14:15:23PRISM Phase 1/2 Study of 4D-150 in Wet AMD: 18-24 Months Extended Follow-Up, First Time Results
/wp-content/uploads/4dmt_logo.svg00Maria Gonzalez/wp-content/uploads/4dmt_logo.svgMaria Gonzalez2026-07-08 12:05:392026-07-15 11:42:48Design and Characterization of 4D-710, an Aerosolized Gene Therapy for Cystic Fibrosis Lung Disease
/wp-content/uploads/4dmt_logo.svg00Maria Gonzalez/wp-content/uploads/4dmt_logo.svgMaria Gonzalez2026-05-21 11:16:182026-05-21 11:21:57Development of a Novel Electro-Chemiluminescent Sandwich Immunoassay for the Detection of CFTR Specific Antibodies
/wp-content/uploads/4dmt_logo.svg00Maria Gonzalez/wp-content/uploads/4dmt_logo.svgMaria Gonzalez2026-05-21 11:06:532026-05-21 11:10:00Development of a Highly Sensitive Cell-based Infectivity Assay for the Assessment of AAV Vector Shedding in Clinical Serum Samples
/wp-content/uploads/4dmt_logo.svg00Adam Chalemian/wp-content/uploads/4dmt_logo.svgAdam Chalemian2025-02-06 11:00:212025-05-19 14:32:44Non-clinical Evaluation of 4D-310 in Combination With Rituximab/Sirolimus: A Translational Study to Support Adoption of a Novel Prophylactic Immunomodulation Regimen in Clinical Trials in Adults with Fabry Disease
/wp-content/uploads/4dmt_logo.svg00Adam Chalemian/wp-content/uploads/4dmt_logo.svgAdam Chalemian2025-02-06 10:57:142026-05-21 11:31:35Phase 1/2 Clinical Trial Evaluating 4d-310 In Adults With Fabry Disease Cardiomyopathy: Interim Analysis of Cardiac and Safety Outcomes in Patients with 21-42 Months of Follow Up (Poster)
/wp-content/uploads/4dmt_logo.svg00Adam Chalemian/wp-content/uploads/4dmt_logo.svgAdam Chalemian2025-02-06 10:55:202025-05-19 14:35:48Phase 1/2 Clinical Trial Evaluating 4d-310 In Adults With Fabry Disease Cardiomyopathy: Interim Analysis of Cardiac and Safety Outcomes in Patients with 21-42 Months of Follow Up
/wp-content/uploads/4dmt_logo.svg00Adam Chalemian/wp-content/uploads/4dmt_logo.svgAdam Chalemian2025-02-06 10:52:532025-05-19 14:37:33Non-clinical Evaluation of 4D-310 in Combination With Rituximab/Sirolimus: A Translational Study to Support Adoption of a Novel Prophylactic Immunomodulation Regimen in Clinical Trials in Adults with Fabry Disease (Poster)
/wp-content/uploads/4dmt_logo.svg00Erik Allison/wp-content/uploads/4dmt_logo.svgErik Allison2024-12-11 14:00:422024-12-11 14:14:40Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies